lung transplantation extracorporeal membrane oxygenation Z94.2
Conditions
Interventions
Group 1: Unfractioned heparin (UFH) for anticoagulation during ECMO therapy.
Group 2: Low molecular weight heparin (LMWH) for anticoagulation during ECMO therapy.
Sponsors
Medizinische Universität WienUniversitätsklinik für Anästhesie, Allgemeine Intensivmedizin und Schmerztherapie
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: - lung transplantation - between 01/01/2006 and 04/30/2017 - perioperative ECMO support - anticoagulation with UFH or LMWH - acceptable data consistency
Exclusion criteria
Exclusion criteria: none
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The history of included patients will be screende for severe bleeding events (surgical intervention for bleeding control, intracranial bleeding, uncontrollable bleeding). | — |
Secondary
| Measure | Time frame |
|---|---|
| The history of included patients will be screened for thromboembolic events (arterial thromboembolic events, including myocardial infarction and stroke, venous thromboembolism including pulmonary embolism and extracorporeal thrombosis). | — |
Countries
Austria
Contacts
Public ContactJohannes Gratz
Medizinische Universität WienUniversitätsklinik für Anästhesie, Allgemeine Intensivmedizin und Schmerztherapie
Outcome results
None listed